We are monitoring the impact of COVID-19 & Recession alarm on MEA DNA Sequencing Market Get in touch with us for detailed analysis Know More

Know More

Share on

Middle East & Africa DNA Sequencing Market Research Report – Segmented By Product & Services, Technology, Workflow, Application, End User, and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 11718
Pages: 90

MEA DNA Sequencing Market Size (2022 to 2027)

The Middle East & Africa DNA sequencing market size is estimated to grow at a moderate CAGR during the forecast period.

DNA sequencing has applications in the research of animal and plant breeding. Selecting the best animals for next-generation breeding requires a thorough understanding of livestock genetics. Genomic technologies are fully established inbreeding and are becoming increasingly efficient due to innovations and technological advancements. The field of modern agriculture has instituted techniques such as genome sequencing, genome-wide association, genotyping, and genetic markers. In addition, genome sequencing has achieved satisfactory success in rearing beef and dairy cattle with improved properties in traits such as milk production, meat quality, feed efficiency, and health.

MARKET DRIVERS:

Factors such as constant technological advancements in sequencing methods, advancements in bioinformatics, increasing applications of NGS (Next-Generation Sequencing) and WGS (Whole-Genome Sequencing), increasing prevalence of viral diseases such as SARS and COVID-19, increasing cancer cases globally, and increasing spending on research and development are expected to drive the MEA DNA sequencing market. Other factors such as applications in cancer research, biomarker discovery, personalized medicine, genomic analysis, and forensic science are predicted to accelerate the MEA market for DNA sequencing market. Ongoing collaborations and partnerships among leading market players to launch new and innovative technologies have increased the general market demand for the DNA sequencing market in the MEA region.

High investment in research and development and acquisitions, mergers, and collaborations are the key strategies undertaken by companies operating in the MEA DNA sequencing market.

MARKET RESTRAINTS:

University R&D in developing countries depends mainly on external funding. Despite continued efforts by government and private organizations to fund research worldwide, several academic and research institutes face budget constraints when it comes to purchasing and using advanced equipment and technologies and resultant higher prices. As a result, the installation/expansion of advanced research facilities are hampered in developing countries' academic and research institutes. This is a major barrier to adopting technologies such as DNA sequencing in developing countries in Africa and parts of the Middle East region.

Impact of COVID-19 on the MEA DNA sequencing market:

The COVID-19 pandemic has had a positive impact on the market study as the demand for DNA sequencing technology in developing therapies and diagnostics increases.

Tests for the qualitative detection of SARS-CoV-2 nucleic acid in upper respiratory tract samples from individuals suspected of COVID-19. Therefore, due to the increase in research and development activities based on DNA sequencing in developing diagnostic tools or effective therapies for COVID-19, the market is expected to flourish at a significant growth rate.

Recently, researchers at the University of Birmingham developed a COVID-19 test that cuts the test time from 30 minutes to less than 5 minutes and shows accurate results. This method uses a DNA sequence (called a binder DNA) that identifies and binds the SARS-CoV-2 viral RNA and an enzyme that identifies the binder DNA and cuts a small section if the viral RNA exists. An exponential increase in COVID-19 cases has spurred demand for these technologies in large-scale rapid genomic sequencing projects to monitor the viral spread and guide future treatments. The aforementioned factor is boosting the demand for DNA sequencing the diagnosis of COVID-19.

This research report on the MEA DNA sequencing market has been segmented and sub-segmented into the following categories.

By Product & Services:

  • Consumables
  • Instruments
  • Services

By Technology:

  • Sanger Sequencing
  • Next-Generation Sequencing
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Targeted Sequencing & Resequencing
  • Third Generation DNA Sequencing  
  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing

By Workflow:

  • Pre-sequencing
  • Sequencing
  • Data Analysis

By Application:

  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Agri genomics & Forensics
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Consumer Genomics
  • Others

By End-use:

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other Users

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, among MEA, the Middle East region is expected to account for a significant share during the forecast period. The availability of decent healthcare infrastructure has enabled Middle East to gain a major share in the MEA DNA sequencing market. The presence of various government initiatives in the Middle East supports research in drug development and treatment of cancer and other diseases.

The African DNA sequencing market is forecasted to register a moderate CAGR between 2022 and 2027. The strategic initiatives undertaken by international companies to expand their presence due to the high customer base are expected to create many market growth opportunities in the region. Still, a slower growth rate is expected compared to other developed countries due to less awareness.

KEY MARKET PLAYERS:

Companies such as Agilent Technologies, Inc., Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc., LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., SIEMENS AG, PerkinElmer Inc., and Thermo Fisher Scientific, Inc. are playing a leading role in the MEA DNA sequencing market.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year, and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
  6. MARKET SEGMENTATION
    1. Products and Services
      1. Consumables
      2. Instruments
      3. Services
      4. Y-o-Y Growth Analysis, By Products and Services
      5. Market Attractiveness Analysis, By Products and Services
      6. Market Share Analysis, By Products and Services
    2. By Technology
      1. Sanger Sequencing
      2. Next-Generation Sequencing
      3. Whole Genome Sequencing (WGS)
      4. Whole Exome Sequencing (WES)
      5. Targeted Sequencing & Resequencing
      6. Third Generation DNA Sequencing  
      7. Single-Molecule Real-Time Sequencing (SMRT)
      8. Nanopore Sequencing
      9. Y-o-Y Growth Analysis, By Technology
      10. Market Attractiveness Analysis, By Technology
      11. Market Share Analysis, By Technology
    3. By Workflow
      1. Pre-sequencing
      2. Sequencing
      3. Data Analysis
      4. Y-o-Y Growth Analysis, By Workflow
      5. Market Attractiveness Analysis, By Workflow
      6. Market Share Analysis, By Workflow
    4. By Application
      1. Oncology
      2. Reproductive Health
      3. Clinical Investigation
      4. Agri genomics & Forensics
      5. HLA Typing/Immune System Monitoring
      6. Metagenomics, Epidemiology & Drug Development
      7. Consumer Genomics
      8. Others
      9. Y-o-Y Growth Analysis, By Application
      10. Market Attractiveness Analysis, By Application
      11. Market Share Analysis, By Application
    5. By End-User
      1. Academic Research
      2. Clinical Research
      3. Hospitals & Clinics
      4. Pharmaceutical & Biotechnology Companies
      5. Other Users
      6. Y-o-Y Growth Analysis, By End User
      7. Market Attractiveness Analysis, By End User
      8. Market Share Analysis, By End User
  7. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Middle East and Africa
      1. Introduction
      2. Middle East
      3. Africa
  8. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. The threat of New Entrants
      4. The threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  9. MARKET LEADERS' ANALYSIS
    1. Abbott Laboratories
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Agilent Technologies, Inc.
    3. Danaher Corporation (Beckman Coulter, Inc.)
    4. F. Hoffmann-La Roche Ltd
    5. Illumina, Inc.
    6. LI-COR Biosciences, Inc.
    7.  Pacific Biosciences of California, Inc.
    8.  SIEMENS AG
    9. PerkinElmer Inc.,
    10. Thermo Fisher Scientific, Inc.
  10. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations, and Joint Ventures
    4. New Product Launches
  11. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  12. APPENDIX
    1. List of Tables
    2. List of Figures
  1. Middle East and Africa DNA Sequencing Market, By Product & Services, From 2022 - 2027 (USD Billion)
  2. Middle East and Africa Consumables Market, By Region, From 2022 - 2027 (USD Billion)
  3. Middle East and Africa Instruments Market, By Region, From 2022 - 2027 (USD Billion)
  4. Middle East and Africa Services Market, By Region, From 2022 - 2027 (USD Billion)
  5. Middle East and Africa DNA Sequencing Market, By Technology, From 2022 - 2027 (USD Billion)
  6. Middle East and Africa Sanger Sequencing Market, By Region, From 2022 - 2027 (USD Billion)
  7. Middle East and Africa Next-Generation Sequencing Market, By Region, From 2022 - 2027 (USD Billion)
  8. Middle East and Africa Whole Genome Sequencing (WGS) Market, By Region, From 2022 - 2027 (USD Billion)
  9. Middle East and Africa Whole Exome Sequencing (WES) Market, By Region, From 2022 - 2027 (USD Billion)
  10. Middle East and Africa Targeted Sequencing & Resequencing Market, By Region, From 2022 - 2027 (USD Billion)
  11. Middle East and Africa Third Generation DNA Sequencing   Market, By Region, From 2022 - 2027 (USD Billion)
  12. Middle East and Africa Single-Molecule Real-Time Sequencing (SMRT) Market, By Region, From 2022 - 2027 (USD Billion)
  13. Middle East and Africa Nanopore Sequencing Market, By Region, From 2022 - 2027 (USD Billion)
  14. Middle East and Africa DNA Sequencing Market, By Workflow, From 2022 - 2027 (USD Billion)
  15. Middle East and Africa Pre-sequencing Market, By Region, From 2022 - 2027 (USD Billion)
  16. Middle East and Africa Sequencing Market, By Region, From 2022 - 2027 (USD Billion)
  17. Middle East and Africa Data Analysis Market, By Region, From 2022 - 2027 (USD Billion)
  18. Middle East and Africa DNA Sequencing Market, By Application, From 2022 - 2027 (USD Billion)
  19. Middle East and Africa Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  20. Middle East and Africa Reproductive Health Market, By Region, From 2022 - 2027 (USD Billion)
  21. Middle East and Africa Clinical Investigation Market, By Region, From 2022 - 2027 (USD Billion)
  22. Middle East and Africa Agrigenomics & Forensics Market, By Region, From 2022 - 2027 (USD Billion)
  23. Middle East and Africa HLA Typing/Immune System Monitoring Market, By Region, From 2022 - 2027 (USD Billion)
  24. Middle East and Africa Metagenomics, Epidemiology & Drug Development Market, By Region, From 2022 - 2027 (USD Billion)
  25. Middle East and Africa Consumer Genomics Market, By Region, From 2022 - 2027 (USD Billion)
  26. Middle East and Africa Others Market, By Region, From 2022 - 2027 (USD Billion)
  27. Middle East and Africa DNA Sequencing Market, By End-use, From 2022 - 2027 (USD Billion)
  28. Middle East and Africa Academic Research Market, By Region, From 2022 - 2027 (USD Billion)
  29. Middle East and Africa Clinical Research Market, By Region, From 2022 - 2027 (USD Billion)
  30. Middle East and Africa Hospitals & Clinics Market, By Region, From 2022 - 2027 (USD Billion)
  31. Middle East and Africa Pharmaceutical & Biotechnology Companies Market, By Region, From 2022 - 2027 (USD Billion)
  32. Middle East and Africa Other Users Market, By Region, From 2022 - 2027 (USD Billion)
  33. Middle East DNA Sequencing Market, By Product & Services, From 2022 - 2027 (USD Billion)
  34. Middle East DNA Sequencing Market, By Technology, From 2022 - 2027 (USD Billion)
  35. Middle East DNA Sequencing Market, By Workflow, From 2022 - 2027 (USD Billion)
  36. Middle East DNA Sequencing Market, By Application, From 2022 - 2027 (USD Billion)
  37. Middle East DNA Sequencing Market, By End-use, From 2022 - 2027 (USD Billion)
  38. Africa DNA Sequencing Market, By Product & Services, From 2022 - 2027 (USD Billion)
  39. Africa DNA Sequencing Market, By Technology, From 2022 - 2027 (USD Billion)
  40. Africa DNA Sequencing Market, By Workflow, From 2022 - 2027 (USD Billion)
  41. Africa DNA Sequencing Market, By Application, From 2022 - 2027 (USD Billion)
  42. Africa DNA Sequencing Market, By End-use, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample